ロード中...
Comparable Efficacy and Safety of Teriflunomide versus Dimethyl Fumarate for the Treatment of Relapsing-Remitting Multiple Sclerosis
BACKGROUND: The aim of this observational study is to investigate the efficacy and safety of two approved oral disease-modifying therapies (DMTs) in patients with remitting-relapsing multiple sclerosis (RRMS): dimethyl fumarate (DMF) vs. teriflunomide (TRF). METHODS: A total of 159 RRMS patients (82...
保存先:
| 出版年: | Neurol Res Int |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hindawi
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8298169/ https://ncbi.nlm.nih.gov/pubmed/34336283 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/6679197 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|